Department of Paediatrics, University of Chieti, Via dei Vestini 31, Chieti, Italy.
Department of Paediatrics, University of Perugia, Piazza dell'Università 1, Perugia, Italy.
Ital J Pediatr. 2021 Dec 15;47(1):237. doi: 10.1186/s13052-021-01182-6.
A retrospective study was conducted in order to investigate and describe the characteristics of Immunoglobulin A vasculitis (IgAV), previously known as Henoch-Schӧnlein purpura, in the paediatric population of a community-based healthcare delivery system in the Italian region of Abruzzo.
This is a population-based retrospective chart review of the diagnosis of IgAV in children ages 0 to 18, admitted to the Department of Paediatrics of Chieti and Pescara between 1 January 2000 and 31 December 2016. All children enrolled presented with clinical symptoms and laboratory findings and met the EULAR/PRINTO/PRES 2008 criteria.
Two-hundred-eight children met the criteria for IgAV, with the highest incidence reported among children below 7-years of age. A correlation with recent infections was found in 64% of the cohort; the onset was more frequently during the winter and fall. Purpura had a diffuse distribution in the majority of patients; joint impairment was the second most frequent symptom (43%), whereas the gastrointestinal tract was involved in 28% of patients.
Hereby, we confirm the relative benignity of IgAV in a cohort of Italian children; with regards to renal involvement, we report a better outcome compared to other studies. However, despite the low rate of renal disease, we observed a wide use of corticosteroids, especially for the treatment of persistent purpura.
为了调查和描述意大利阿布鲁佐地区社区医疗服务系统中儿童免疫球蛋白 A 血管炎(以前称为过敏性紫癜)的特征,进行了一项回顾性研究。
这是一项针对 2000 年 1 月 1 日至 2016 年 12 月 31 日期间在基耶蒂和佩斯卡拉儿科部门就诊的年龄在 0 至 18 岁之间的 IgAV 儿童的基于人群的回顾性图表审查。所有入组的儿童均出现临床症状和实验室发现,并符合 EULAR/PRINTO/PRES 2008 标准。
208 名儿童符合 IgAV 标准,发病率最高的是 7 岁以下的儿童。在队列的 64%中发现了与近期感染的相关性;发病更常见于冬季和秋季。紫癜在大多数患者中呈弥漫性分布;关节损伤是第二常见的症状(43%),而 28%的患者胃肠道受累。
在此,我们确认了意大利儿童队列中 IgAV 的相对良性;关于肾脏受累,我们报告的结果优于其他研究。然而,尽管肾脏疾病的发生率较低,但我们观察到皮质类固醇的广泛使用,尤其是用于治疗持续性紫癜。